Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias
Authors:
- Bruna Victorasso JardimBJBruna Victorasso Jardim
- Camila LeonelCLCamila Leonel
- Marina Gobbe MoschettaMMMarina Gobbe Moschetta
- Debora Ap. Pires de Campos ZuccariDZDebora Ap. Pires de Campos Zuccari
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 146 (2) , 106-112
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Determination of the LOQ in real-time PCR by receiver operating characteristic curve analysis: application to qPCR assays for Fusarium verticillioides and F. proliferatumAnalytical and Bioanalytical Chemistry, 2011
- Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2009
- Integrative Genomic Data Mining for Discovery of Potential Blood-Borne Biomarkers for Early Diagnosis of CancerPLOS ONE, 2008
- Serum and urine levels of interleukin-8 in patients with non-Hodgkin’s lymphomaCytokine, 2008
- Immunohistochemical evaluation of e-cadherin, Ki-67 and PCNA in canine mammary neoplasias: correlation of prognostic factors and clinical outcomePesquisa Veterinária Brasileira, 2008
- Expression of Angiogenic Factors Vascular Endothelial Growth Factor and Interleukin-8/CXCL8 Is Highly Responsive to Ambient Glutamine AvailabilityCancer Research, 2004
- Inflammation and cancerNature, 2002
- Correlação entre a citologia aspirativa por agulha fina e a histologia no diagnóstico de tumores mamários de cadelasBrazilian Journal of Veterinary Research and Animal Science, 2001
- Purification of melanoma growth stimulatory activityJournal of Cellular Physiology, 1986
- Comparison of age, sex, and incidence rates in human and canine breast cancerCancer, 1970